Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Eagle Pharmaceuticals, Inc. (EGRX)

« Back to company index

EGRX Chatter Timeline

Stock Ticker for EGRX

Most Active Tweeters for EGRX

UserTweets
@Tickeron 8
@newsfilterio 6
@FlashAlert_me 5
@equity_newswire 2
@toggle_ai 2

Recent Tweets for EGRX

Tickeron @Tickeron
$EGRX enters a Downtrend because Momentum Indicator dropped below the 0 level on April 26, 2021. View odds for this… https://t.co/TYkH5uhEF6
May 8th 2021, 10:05pm
toggle_ai @toggle_ai
$EGRX:NASD - Eagle Pharmaceuticals's price could increase 8.09% after its trend switched negative [… https://t.co/j4kLpl3EHq
May 8th 2021, 4:05pm
lunatictrader1 @lunatictrader1
Daily reversal levels for next Monday. Buy signal for $CIEN. Bullish divergence for $EGRX. Partial profits signal f… https://t.co/Xn73YvSYBS
May 8th 2021, 9:05am
Tickeron @Tickeron
$EGRX enters a Downtrend because Momentum Indicator dropped below the 0 level on April 26, 2021. View odds for this… https://t.co/hNieoQ1Fkj
May 8th 2021, 3:05am
JDruryPartners @JDruryPartners
Eagle Pharmaceuticals adds Luciana Borio (Fmr Acting Chief Scientist, U.S. FDA) to Board $EGRX #corpgov https://t.co/BozSeEQiMT
May 7th 2021, 11:05pm
Tickeron @Tickeron
$EGRX in -1.42% Downtrend, declining for three consecutive days on April 30, 2021. View odds for this and other ind… https://t.co/p8PYPzoZJR
May 4th 2021, 3:05am
SmallCapsDaily @SmallCapsDaily
$EGRX Eagle Pharmaceuticals Appoints Former FDA Official and Public Health Expert Dr. Luciana Borio to its Board of… https://t.co/e2Hp7ZXvoJ
May 3rd 2021, 3:05pm
scientwest @scientwest
RT @MarcJacksonLA: $EGRX Eagle Pharmaceuticals Appoints Former FDA Official and Public Health Expert Dr. Luciana Borio to its Board of Dire…
May 3rd 2021, 1:05pm
MarcJacksonLA @MarcJacksonLA
$EGRX Eagle Pharmaceuticals Appoints Former FDA Official and Public Health Expert Dr. Luciana Borio to its Board of… https://t.co/pkSzrgXjS6
May 3rd 2021, 1:05pm
equity_newswire @equity_newswire
$EGRX Eagle Pharmaceuticals Appoints Former FDA Official and Public Health Expert Dr. Luciana Borio to its Board of… https://t.co/PGf99FJPDk
May 3rd 2021, 1:05pm
Tickeron @Tickeron
$EGRX in -1.42% Downtrend, falling for three consecutive days on April 30, 2021. View odds for this and other indic… https://t.co/TnLfEvp5K6
May 3rd 2021, 12:05pm
StockTexts @StockTexts
$EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/ybN81iBtri
May 3rd 2021, 11:05am
EdgarInsider @EdgarInsider
Alert [Press/News Current Report] / Form 8-K filed with the SEC $EGRX #EaglePharmaceuticals, Inc https://t.co/JMrgE2WUki
May 3rd 2021, 11:05am
fintel_io @fintel_io
$EGRX / Eagle Pharmaceuticals files form 8-K - Regulation FD Disclosure, Financial Statements and Exhibits - FORM… https://t.co/CImlZY1Q8Z
May 3rd 2021, 11:05am
FlashAlert_me @FlashAlert_me
$EGRX [15s. delayed] filed form 8-K on May 03, 07:30:14: Item7.01: Regulation FD https://t.co/tD69vRXJIJ
May 3rd 2021, 11:05am
StckPro @StckPro
$EGRX NEW ARTICLE : Eagle Pharmaceuticals Appoints Former FDA Official and Public Health Expert Dr. Luciana Borio t… https://t.co/tSvdDsjNdk
May 3rd 2021, 11:05am
FlashAlert_me @FlashAlert_me
$EGRX [15s. delayed]: Issued Press Release on May 03, 06:50:00: Eagle Pharmaceuticals Appoints Former FDA Official… https://t.co/sw7BmUby6D
May 3rd 2021, 10:05am
stock_titan @stock_titan
$EGRX Eagle Pharmaceuticals Appoints Former FDA Official and Public Health Expert Dr. Luciana Borio to its Board of… https://t.co/iK9cRcMJ1P
May 3rd 2021, 10:05am
toggle_ai @toggle_ai
$EGRX:NASD - Eagle Pharmaceuticals momentum decelerated, in the past this led to a increase in price [… https://t.co/fF2gLNME2D
May 1st 2021, 7:05pm
newsfilterio @newsfilterio
Form 3 (initial statement of beneficial ownership of securities) filed with the SEC $EGRX https://t.co/UJfm8HhTZ7
May 1st 2021, 2:05pm
newsfilterio @newsfilterio
13,500 shares acquired by Borio Luciana (Director), reported in a new form 4 filed with the SEC $EGRX https://t.co/x6ppullwfu
May 1st 2021, 1:05pm
newsfilterio @newsfilterio
Form DEF 14A (other definitive proxy statements) filed with the SEC $EGRX https://t.co/Qq19whZ8ut
May 1st 2021, 1:05pm
newsfilterio @newsfilterio
Form DEFA14A (additional definitive proxy soliciting materials and rule 14(a)(12) material) filed with the SEC $EGRX https://t.co/O8u6e7YI5q
May 1st 2021, 1:05pm
tradersreport @tradersreport
RT @Tickeron: $EGRX enters a Downtrend because Momentum Indicator dropped below the 0 level on April 26, 2021. View odds for this and other…
May 1st 2021, 9:05am
Tickeron @Tickeron
$EGRX enters a Downtrend because Momentum Indicator dropped below the 0 level on April 26, 2021. View odds for this… https://t.co/t5VmrT6Cg8
May 1st 2021, 9:05am
newsfilterio @newsfilterio
Eagle Pharma's Treakisym RTD + rituximab OK'd in Japan for large b-cell lymphoma $EGRX https://t.co/vWI7uuBGPp
May 1st 2021, 1:05am
ExecPayOrg @ExecPayOrg
Eagle Pharmaceuticals CEO Scott Tarriff's 2020 pay rises 20% to $9.5M https://t.co/EJOJ8exBxR $EGRX #execpay
April 30th 2021, 10:04pm
FlashAlert_me @FlashAlert_me
$EGRX [15s. delayed] filed form DEF 14A on April 30, 17:14:58 https://t.co/b8fNdjzyob
April 30th 2021, 9:04pm
StockTexts @StockTexts
$EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/IlOKpZpvts
April 30th 2021, 9:04pm
FlashAlert_me @FlashAlert_me
$EGRX [15s. delayed] filed SEC form 4: Director BORIO LUCIANA: Transacted Derivative Securities on 2021-04-28. https://t.co/yN3sCOBxEe
April 30th 2021, 9:04pm
FlashAlert_me @FlashAlert_me
$EGRX [15s. delayed] filed SEC form 3: Director BORIO LUCIANA: https://t.co/rDWO193zMG
April 30th 2021, 9:04pm
MarcJacksonLA @MarcJacksonLA
$EGRX Eagle Pharmaceuticals Announces TREAKISYM (bendamustine) Ready-to-Dilute (“RTD”) Formulation, in Combination… https://t.co/g20dKY3weK
April 30th 2021, 1:04pm
Briefingcom @Briefingcom
$EGRX: Eagle Pharma announces TREAKISYM (bendamustine) ready-to-dilute formulation, in combination with rituximab... https://t.co/RsvgvuLIDv
April 30th 2021, 12:04pm
equity_newswire @equity_newswire
$EGRX Eagle Pharmaceuticals Announces TREAKISYM (bendamustine) Ready-to-Dilute (“RTD”) Formulation, in Combination… https://t.co/3T4sFFXXkC
April 30th 2021, 12:04pm
glitchbotio @glitchbotio
RT @MarketCurrents: $EGRX - Eagle Pharma's Treakisym RTD + rituximab OK'd in Japan for large b-cell lymphoma https://t.co/9x5XaFOCZL
April 30th 2021, 12:04pm
MarketCurrents @MarketCurrents
$EGRX - Eagle Pharma's Treakisym RTD + rituximab OK'd in Japan for large b-cell lymphoma https://t.co/9x5XaFOCZL
April 30th 2021, 12:04pm
PorqueNoTrade @PorqueNoTrade
$EGRX Announces TREAKISYM, In Combination With Rituximab For Relapsed / Refractory Diffuse Large B-cell Lymphoma R… https://t.co/KK6EcGqH2K
April 30th 2021, 11:04am
sbwcws @sbwcws
Eagle announces approval of Treakisym RTD and rituximab combination in Japan $EGRX
April 30th 2021, 10:04am
stock_titan @stock_titan
$EGRX Eagle Pharmaceuticals Announces TREAKISYM (bendamustine) Ready-to-Dilute (“RTD”) Formulation, in Combination… https://t.co/KqJWBTze5M
April 30th 2021, 10:04am
newsfilterio @newsfilterio
Eagle Pharmaceuticals to Host First Quarter 2021 Financial Results on May 10, 2021 $EGRX https://t.co/KBarIKA2oO
April 30th 2021, 1:04am
Beeken_health @Beeken_health
$EGRX - Eagle Pharmaceuticals to Host First Quarter 2021 Financial Results on May 10, 2021 https://t.co/UwnNAeNNOg https://t.co/lErsAa0VYw
April 29th 2021, 8:04pm
otcdynamics @otcdynamics
$EGRX Eagle Pharmaceuticals to Host First Quarter 2021 Financial Results on May 10, 2021 https://t.co/6cP1ONO8Uh
April 29th 2021, 8:04pm
Tickeron @Tickeron
$EGRX in Downtrend: 50-day Moving Average broke below 200-day Moving Average on March 31, 2021. View odds for this… https://t.co/olPC9BHE29
April 29th 2021, 4:04am
Tickeron @Tickeron
$EGRX in Downtrend: its price may drop because broke its higher Bollinger Band on April 14, 2021. View odds for thi… https://t.co/PZ7lqx2WfX
April 27th 2021, 11:04am
EZMoney_41 @EZMoney_41
$EGRX Now awaiting Buy signal https://t.co/5FW80elpa0
April 26th 2021, 7:04pm
Tickeron @Tickeron
$EGRX in Downtrend: its price may drop because broke its higher Bollinger Band on April 14, 2021. View odds for thi… https://t.co/sNMpaeU3tL
April 26th 2021, 12:04pm
Tickeron @Tickeron
$EGRX in +2.65% Uptrend, rising for three consecutive days on April 21, 2021. View odds for this and other indicato… https://t.co/gMjDbFUOUl
April 23rd 2021, 6:04am
Tickeron @Tickeron
$EGRX in Downtrend: 50-day Moving Average moved below 200-day Moving Average on March 31, 2021. View odds for this… https://t.co/wt1cP2KxU9
April 21st 2021, 10:04pm
Tickeron @Tickeron
$EGRX's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/XHIZelHuJB
April 20th 2021, 5:04am
YouCanFoolMost @YouCanFoolMost
RT @Tickeron: $EGRX's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and…
April 18th 2021, 2:04am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.